CIK 0001585364
- Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +1 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-08 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +920 | $25.72 | $24K | 18,930 |
| 2024-07-08 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −479 | $25.72 | $12K | 18,451 |
| 2024-07-08 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −920 | 919 | ||
| 2024-04-05 | Ives Alison EVP & Chief Scientific Officer | Grant or award · Restricted Stock Units | +7,166 | 7,166 | ||
| 2024-03-07 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +1,746 | $29.69 | $52K | 18,536 |
| 2024-03-07 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −526 | $29.69 | $16K | 18,010 |
| 2024-03-07 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,746 | 1,746 | ||
| 2024-03-06 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +2,030 | $28.09 | $57K | 17,402 |
| 2024-03-06 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −612 | $28.09 | $17K | 16,790 |
| 2024-03-06 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,030 | 4,058 | ||
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +1,698 | $27.26 | $46K | 14,144 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −512 | $27.26 | $14K | 13,632 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Purchase | +2,490 | $27.26 | $68K | 16,122 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −750 | $27.26 | $20K | 15,372 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,698 | 0 | ||
| 2024-02-29 | Ives Alison EVP & Chief Scientific Officer | Purchase | +1,545 | $26.44 | $41K | 12,446 |
| 2023-11-16 | Ives Alison EVP & Chief Scientific Officer | Purchase | +2,040 | $29.34 | $60K | 10,901 |
| 2023-11-16 | Ives Alison EVP & Chief Scientific Officer | Purchase | +2,040 | $29.34 | $60K | 10,380 |
| 2023-10-06 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +738 | $30.46 | $22K | 9,078 |
| 2023-10-06 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −217 | $30.46 | $7K | 8,861 |
Page 1 of 2 · 28 trades